In-Vitro Toxicology Testing Market to Hit $18.6 billion by 2027 | Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), Bio-Rad Laboratories, Inc. (US), General Electric Company (US)

According to the new market research report "In-Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma, Biotech) - Global Forecast to 2027", The in vitro toxicology testing market is projected to reach USD 18.6 billion by 2027 from USD 11.2 billion in 2022, at a CAGR of 10.8% during the forecast period.

Browse in-depth TOC on "In Vitro Toxicology Testing Market"
329 - Tables
47 - Figures
370 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065&utm_source=OPenpr&utm_campaign=paid&utm_content=Referral

The increasing focus of the pharmaceutical and cosmetics industries on using in vitro methods for product testing along with the improving in silico methods for predictive toxicology studies are also expected to offer significant growth opportunities for players in this market.

The global in vitro toxicology testing market is consolidated at the top with a large number of leading market players based in developed countries. The prominent players in this market are Thermo Fisher Scientific Inc. (US), Laboratory Corporation of America Holdings (US), Bio-Rad Laboratories, Inc. (US), General Electric Company (US), Eurofins Scientific (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International (US), Catalent (US), Evotec (UK), Promega Corporation (US), and Gentronix Limited (UK). Due to the intense competition in the market, major market players are increasingly focusing on expanding their geographic presence into the high growth emerging markets and strengthening their competitiveness in the market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209577065&utm_source=OPenpr&utm_campaign=paid&utm_content=Referral

The in vitro toxicology testing market is segmented based on the product and service, method, industry, technology, toxicity endpoint & test, and region. Based on product and service, the software segment is projected to witness the highest growth in the in vitro toxicology testing market during the forecast period. Growth in this segment is driven largely by the growing use of assays to make up the basic screening mutagenicity properties of various chemicals and substances.

Based on technologies used in in vitro toxicology testing, the market is divided into cell culture technologies, high-throughput technologies, and toxicogenomics. The cell culture technologies segment held the largest share of the market in 2021. The large share of this segment can be attributed to the fact that it is the most preferred technique for toxicity testing, being capable of mimicking in vivo conditions.

The in vitro toxicology testing market by method is mainly segmented into cellular assays, biochemical assays, in silico models, and ex vivo models. The in-silico models are expected to register the highest CAGR during the forecast period. This is attributed to the increasing use of computer-aided models for toxicological research by integrating modern computing with molecular biology.

Based on industry, the pharmaceutical & biopharmaceutical industry segment held the largest share of the market in 2021, owing to factors such as the mandatory preclinical safety evaluation for drug registration coupled with the rising investments in the research of new molecules to meet the current and future healthcare challenges.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=209577065&utm_source=OPenpr&utm_campaign=paid&utm_content=Referral

Geographical Growth Scenario:

Geographically, the in vitro toxicology testing market in Asia Pacific is expected to be the fastest-growing regional market. The high growth of this regional market is attributed primarily to factors such as increasing pharmaceutical drug pipeline, the growing emergence of CROs, opposition to animal testing resulting in the use of alternate methods, and growing consumer awareness of product safety.

Key Players:

The prominent players in the in vitro toxicology testing market include Thermo fisher Scientific, Inc. (US), Laboratory Corporation of America Holdings (US), Bio-Rad Laboratories, Inc. (US), General Electric Company (US), Eurofins Scientific (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Evotec (UK), SGS S.A. (Switzerland), QIAGEN (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.